Comparing Synergy CHC (NASDAQ:SNYR) & Procter & Gamble (NYSE:PG)

Procter & Gamble (NYSE:PG) and Synergy CHC (NASDAQ:SNYR) are both consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, dividends, earnings and risk.

Valuation & Earnings

This table compares Procter & Gamble and Synergy CHC”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Procter & Gamble	$84.93 billion	3.90	$15.97 billion	$6.85	20.70
Synergy CHC	$34.83 million	0.58	$2.12 million	$0.29	6.24

Procter & Gamble has higher revenue and earnings than Synergy CHC. Synergy CHC is trading at a lower price-to-earnings ratio than Procter & Gamble, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Procter & Gamble has a beta of 0.39, indicating that its share price is 61% less volatile than the S&P 500. Comparatively, Synergy CHC has a beta of 3.48, indicating that its share price is 248% more volatile than the S&P 500.

Insider and Institutional Ownership

65.8% of Procter & Gamble shares are held by institutional investors. 0.2% of Procter & Gamble shares are held by company insiders. Comparatively, 56.6% of Synergy CHC shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Procter & Gamble and Synergy CHC’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Procter & Gamble	19.74%	32.63%	13.53%
Synergy CHC	7.77%	-19.51%	14.25%

Analyst Ratings

This is a summary of recent recommendations and price targets for Procter & Gamble and Synergy CHC, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Procter & Gamble	0	10	15	0	2.60
Synergy CHC	0	1	2	0	2.67

Procter & Gamble currently has a consensus target price of $169.23, suggesting a potential upside of 19.33%. Synergy CHC has a consensus target price of $8.50, suggesting a potential upside of 369.61%. Given Synergy CHC’s stronger consensus rating and higher probable upside, analysts clearly believe Synergy CHC is more favorable than Procter & Gamble.

Summary

Procter & Gamble beats Synergy CHC on 9 of the 14 factors compared between the two stocks.

About Procter & Gamble

Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH.

About Synergy CHC

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.